TCL Archive Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer June 24, 2005
TCL Archive Pazdur: Registration Trials Run By Groups Need Same Rigor As Industry Trials March 25, 2011
TCL Archive In Brief: MD Anderson’s DuBois Named head of Arizona State’s Biodesign Institute October 5, 2012
TCL Archive CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely May 23, 2003
TCL Archive Tarceva-Induced Rash Strongly Associated With Longer Survival, Sponsor Finds July 27, 2007
